Comparative efficacy and safety of apixaban and rivaroxaban versus warfarin in atrial fibrillation patients with end-stage renal disease: a systematic review and meta-analysis
This study aimed to evaluate the comparative efficacy and safety of apixaban and rivaroxaban versus vitamin K antagonists (VKAs) in anticoagulation management in a dialysis population. PubMed, Embase, and the Cochrane Library were searched for studies comparing apixaban or rivaroxaban with VKAs in p...
שמור ב:
| Principais autores: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis Group
2026-12-01
|
| סדרה: | Renal Failure |
| נושאים: | |
| גישה מקוונת: | https://www.tandfonline.com/doi/10.1080/0886022X.2026.2666454 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|